These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20138067)

  • 1. Oral sensory and cephalic hormonal responses to fat and non-fat liquids in bulimia nervosa.
    Bello NT; Coughlin JW; Redgrave GW; Moran TH; Guarda AS
    Physiol Behav; 2010 Apr; 99(5):611-7. PubMed ID: 20138067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tasting fat: cephalic phase hormonal responses and food intake in restrained and unrestrained eaters.
    Crystal SR; Teff KL
    Physiol Behav; 2006 Sep; 89(2):213-20. PubMed ID: 16846622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified sham feeding of foods with different macronutrient compositions differentially influences cephalic change of insulin, ghrelin, and NMR-based metabolomic profiles.
    Zhu Y; Hsu WH; Hollis JH
    Physiol Behav; 2014 Aug; 135():135-42. PubMed ID: 24952264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced ghrelin secretion in the cephalic phase of food ingestion in women with bulimia nervosa.
    Monteleone P; Serritella C; Scognamiglio P; Maj M
    Psychoneuroendocrinology; 2010 Feb; 35(2):284-8. PubMed ID: 19631473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women.
    Naessén S; Carlström K; Byström B; Pierre Y; Hirschberg AL
    Psychoneuroendocrinology; 2007 Jun; 32(5):548-54. PubMed ID: 17475412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meal-induced compositional changes in blood and saliva in persons with bulimia nervosa.
    Dynesen AW; Bardow A; Astrup A; Petersson B; Holst JJ; Nauntofte B
    Am J Clin Nutr; 2008 Jan; 87(1):12-22. PubMed ID: 18175732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of naltrexone to affect the pleasantness or intake of food.
    Hetherington MM; Vervaet N; Blass E; Rolls BJ
    Pharmacol Biochem Behav; 1991 Sep; 40(1):185-90. PubMed ID: 1780340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hunger and satiety responses to high-fat meals after a high-polyunsaturated fat diet: A randomized trial.
    Stevenson JL; Paton CM; Cooper JA
    Nutrition; 2017 Sep; 41():14-23. PubMed ID: 28760423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin and leptin responses to food ingestion in bulimia nervosa: implications for binge-eating and compensatory behaviours.
    Monteleone P; Martiadis V; Fabrazzo M; Serritella C; Maj M
    Psychol Med; 2003 Nov; 33(8):1387-94. PubMed ID: 14672247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone and metabolite plasma levels after oral glucose in bulimia and healthy controls.
    Casper RC; Pandy GN; Jaspan JB; Rubenstein AH
    Biol Psychiatry; 1988 Oct; 24(6):663-74. PubMed ID: 3048427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement.
    Drewnowski A; Krahn DD; Demitrack MA; Nairn K; Gosnell BA
    Physiol Behav; 1992 Feb; 51(2):371-9. PubMed ID: 1313591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological, hormonal and biochemical changes following carbohydrate bingeing: a placebo controlled study in bulimia nervosa and matched controls.
    Turner MS; Foggo M; Bennie J; Carroll S; Dick H; Goodwin GM
    Psychol Med; 1991 Feb; 21(1):123-33. PubMed ID: 2047488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind placebo-controlled glucose challenge in bulimia nervosa: psychological effects.
    Blouin AG; Blouin J; Bushnik T; Braaten J; Goldstein C; Sarwar G
    Biol Psychiatry; 1993 Feb; 33(3):160-8. PubMed ID: 8448264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans.
    Bertino M; Beauchamp GK; Engelman K
    Am J Physiol; 1991 Jul; 261(1 Pt 2):R59-63. PubMed ID: 1858956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified sham feeding of sweet solutions in women with and without bulimia nervosa.
    Klein DA; Schebendach JE; Brown AJ; Smith GP; Walsh BT
    Physiol Behav; 2009 Jan; 96(1):44-50. PubMed ID: 18773914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the categorization process among patients with eating disorders: a new cognitive approach to psychopathology].
    Urdapilleta I; Mirabel-Sarron C; Meunier JM; Richard JF
    Encephale; 2005; 31(1 Pt 1):82-91. PubMed ID: 15971644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential responses of circulating amylin to high-fat vs. high-carbohydrate meal in healthy men.
    Eller LK; Ainslie PN; Poulin MJ; Reimer RA
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):890-7. PubMed ID: 18031323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial.
    Faris PL; Kim SW; Meller WH; Goodale RL; Oakman SA; Hofbauer RD; Marshall AM; Daughters RS; Banerjee-Stevens D; Eckert ED; Hartman BK
    Lancet; 2000 Mar; 355(9206):792-7. PubMed ID: 10711927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa.
    Monteleone P; Martiadis V; Rigamonti AE; Fabrazzo M; Giordani C; Muller EE; Maj M
    Biol Psychiatry; 2005 Apr; 57(8):926-31. PubMed ID: 15820714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appetite-related gut peptides, ghrelin, PYY, and GLP-1 in obese women with and without binge eating disorder (BED).
    Geliebter A; Hashim SA; Gluck ME
    Physiol Behav; 2008 Aug; 94(5):696-9. PubMed ID: 18534636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.